Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kelly Blum
Institutions:
University of California, San Francisco,
UCSF Helen Diller Family Comprehensive Cancer Center
Observed institutions:
University of Nebraska at Omaha,
University of Pittsburgh,
University of California, San Francisco,
Stanford Medicine,
UCSF Helen Diller Family Comprehensive Cancer Center,
Stanford University
show all 6
ORCID:
0009-0009-0744-8143
Observed ORCID:
0009-0009-0744-8143
OpenAlex ID:
A5077303647
Interpersonal psychotherapy delivered by nonspecialists for depression and posttraumatic stress disorder among Kenyan HIV–positive women affected by gender-based violence: Randomized controlled trial
2021
·
Susan M. Meffert
, Thomas C. Neylan
, et al.
·
PLoS Medicine
·
67
Risk-Based vs Annual Breast Cancer Screening
2025
·
Laura J. Esserman
, Allison S. Fiscalini
, et al.
·
JAMA
·
53
Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)
2025
·
Laura A. Huppert
, Reshma Mahtani
, et al.
·
npj Breast Cancer
·
53
PDF
Low socioeconomic status is associated with lower weight-loss outcomes 10-years after Roux-en-Y gastric bypass
2018
·
Anthony Carden
, Kelly Blum
, et al.
·
Surgical Endoscopy
·
40
Implementation research for public sector mental health care scale-up (SMART-DAPPER): a sequential multiple, assignment randomized trial (SMART) of non-specialist-delivered psychotherapy and/or medication for major depressive disorder and posttraumatic stress disorder (DAPPER) integrated with outpatient care clinics at a county hospital in Kenya
2019
·
Rachel Levy
, Muthoni Mathai
, et al.
·
BMC Psychiatry
·
22
PDF
Treatment rechallenge after trastuzumab-deruxtecan–related interstitial lung disease: A multi-institution cohort study.
2025
·
Kelsey H. Natsuhara
, Kelly Blum
, et al.
·
Journal of Clinical Oncology
·
13
PDF
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer
2025
·
Jennifer R. Grandis
, Katherine A. Skorupski
, et al.
·
Cancer Cell
·
11
Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC Tumors
2025
·
Jacqueline P. Nguyen
, Shorook Na’ara
, et al.
·
Molecular Cancer Therapeutics
·
5
Germline Pathogenic Variants Among Women Without a History of Breast Cancer
2025
·
Kirkpatrick B. Fergus
, Katherine S. Ross
, et al.
·
JAMA Internal Medicine
·
4
Variation in Center-Level Frailty Burden and Its Impact on Long-Term Survival in Patients Undergoing Repair for Abdominal Aortic Aneurysms
2018
·
Elizabeth L. George
, Kelly Blum
, et al.
·
Journal of Vascular Surgery
·
4
PDF
Multi-institutional analysis of incidence and risks for late-onset immune toxicity in breast cancer
2025
·
Saya Jacob
, Samantha Fisch
, et al.
·
npj Breast Cancer
·
3
PDF
WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design
2026
·
Allison Fiscalini
, Kelly Blum
, et al.
·
npj Breast Cancer
·
2
PDF
Interaction of Frailty and Postoperative Complications on Unplanned Readmission after Elective Outpatient Surgery
2018
·
Jordan R. Stern
, Kelly Blum
, et al.
·
Journal of the American College of Surgeons
·
2
Causal decomposition framework for quantifying intervenable cancer health disparities
2026
·
Fan Xia
, Sang Kyu Lee
, et al.
·
Biometrics
Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations
2026
·
Yiwey Shieh
, Rachel S. Heise
, et al.
·
JAMA Oncology
Abstract PS5-05: Late-onset immune toxicity incidence & risk factors in breast cancer: a multi-institutional study
2025
·
Saya Jacob
, Samantha Fisch
, et al.
·
Clinical Cancer Research
Supplemental Figure 1 from Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC Tumors
2025
·
Jacqueline P. Nguyen
, Shorook Na’ara
, et al.
Supplemental Figure 3 from Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC Tumors
2025
·
Jacqueline P. Nguyen
, Shorook Na’ara
, et al.
Supplemental Figure 2 from Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC Tumors
2025
·
Jacqueline P. Nguyen
, Shorook Na’ara
, et al.
Data from Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC Tumors
2025
·
Jacqueline P. Nguyen
, Shorook Na’ara
, et al.
Show more works
View as search
Works count:
20
Citation count:
279
H-index:
7
I10-index:
7
Year
Topic
Type